Estimated direct costs of non-small cell lung cancer by stage at diagnosis and disease management phase: A whole-disease model.

ABSTRACT:

Background

Non-small cell lung cancer (NSCLC) is the first cause of cancer-related death among men and the second among women worldwide. It also poses an economic threat to the sustainability of healthcare services. This study estimated the direct costs of care for patients with NSCLC by stage at diagnosis, and management phase of pathway recommended in local and international guidelines.

Methods

Based on the most up-to-date guidelines, we developed a very detailed "whole-disease" model listing the probabilities of all potentially necessary diagnostic and therapeutic actions involved in the management of each stage of NSCLC. We assigned a cost to each procedure, and obtained an estimate of the total and average per-patient costs of each stage of the disease and phase of its

SUBMITTER: Buja A 

PROVIDER: S-EPMC7779199 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature